Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy.
Christopher JohnsSteven K MontalvoM'Kay CaubleYu-Lun LiuSean AllAsal S RahimiPrasanna G AlluriAnn Marilyn LeitchNisha UnniRachel WooldridgeDeborah FarrChika NwachukwuD W Nathan KimPublished in: Breast cancer research and treatment (2023)
For non-responders, particularly ypN + patients, ASA use associated with improved outcome. These hypotheses-generating results suggest for development of prospective clinical trials of augmented ASA use in selected very high-risk BC patients.
Keyphrases
- neoadjuvant chemotherapy
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- lymph node
- randomized controlled trial
- peritoneal dialysis
- low dose
- squamous cell carcinoma
- coronary artery disease
- locally advanced
- type diabetes
- early stage
- patient reported outcomes
- percutaneous coronary intervention
- open label